BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12645494)

  • 1. Education for continuous subcutaneous insulin infusion pump users.
    American Association of Diabetes Educators
    Diabetes Educ; 2003; 29(1):97-9. PubMed ID: 12645494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Education of the patient for therapy with personal insulin pump].
    Benbenek-Klupa T
    Przegl Lek; 2006; 63(5):292-5. PubMed ID: 17036508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AADE position statement: education for continuous subcutaneous insulin infusion pump users. American Association of Diabetes Educators.
    Diabetes Educ; 1997; 23(4):397-8. PubMed ID: 9305004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pumps in children with diabetes.
    Clark LM; Plotnick LP
    J Pediatr Health Care; 1990; 4(1):3-10. PubMed ID: 2405149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus evidence-based guidelines for use of insulin pump therapy in the management of diabetes as per Indian clinical practice.
    Kesavadev J; Jain SM; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):34-41. PubMed ID: 25668935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived Benefits and Barriers Regarding CSII Treatment: Development and Psychometric Evaluation of the Insulin Pump Attitudes Questionnaire (IPA-Questionnaire).
    Bergis D; Roos T; Ehrmann D; Schmitt A; Schipfer M; Haak T; Kulzer B; Hermanns N
    Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):566-573. PubMed ID: 31426110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin Pumps: Review of Technological Advancement in Diabetes Management.
    Sora ND; Shashpal F; Bond EA; Jenkins AJ
    Am J Med Sci; 2019 Nov; 358(5):326-331. PubMed ID: 31655714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family perceptions of insulin pump adverse events in children and adolescents.
    Wheeler BJ; Donaghue KC; Heels K; Ambler GR
    Diabetes Technol Ther; 2014 Apr; 16(4):204-7. PubMed ID: 24313790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of continuous subcutaneous insulin infusion (CSII) therapy in pediatric diabetes patients in the perioperative period.
    Vanderhoek SM; Wolf RM
    Paediatr Anaesth; 2019 Sep; 29(9):901-906. PubMed ID: 31325198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of insulin pumps, even in adolescent use, depends on thorough patient selection, evaluation, and education.
    Exelbert LL
    Pediatrics; 2008 Sep; 122(3):682; author reply 682-3. PubMed ID: 18762546
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient management of long-term continuous subcutaneous insulin infusion.
    Johansson UB; Adamson U; Lins PE; Wredling R
    J Adv Nurs; 2005 Jul; 51(2):112-8. PubMed ID: 15963182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [External insulin pump treatment].
    Puech-Bret N; Guillaume E
    Soins; 2014 Apr; (784):23-6. PubMed ID: 24839678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical management of a diabetic patient treated with an implantable insulin pump].
    Selam JL; Haardt MJ; Bethoux JP; Slama G
    Diabete Metab; 1991; 17(6):545-8. PubMed ID: 1809602
    [No Abstract]   [Full Text] [Related]  

  • 15. [Systems of continuous subcutaneous insulin infusion. Therapeutic education program].
    Galindo Rubio M
    Rev Enferm; 2011 Jun; 34(6):24-30. PubMed ID: 21830364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience.
    Maurizi AR; Suraci C; Pitocco D; Schiaffini R; Tubili C; Morviducci L; Giordano R; Manfrini S; Lauro D; Frontoni S; Pozzilli P; Buzzetti R;
    J Diabetes; 2016 Jan; 8(1):41-4. PubMed ID: 26118939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme subcutaneous insulin resistance successfully treated by an implantable pump.
    Riveline JP; Capeau J; Robert JJ; Varroud-Vial M; Cerf-Baron I; Deburge A; Charpentier G
    Diabetes Care; 2001 Dec; 24(12):2155-6. PubMed ID: 11723102
    [No Abstract]   [Full Text] [Related]  

  • 18. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
    Szypowska A; PaƄkowska E; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical pearls in insulin pump therapy.
    Hirsch IB
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S23-7. PubMed ID: 20515302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin pump-associated adverse events in children and adolescents--a prospective study.
    Wheeler BJ; Heels K; Donaghue KC; Reith DM; Ambler GR
    Diabetes Technol Ther; 2014 Sep; 16(9):558-62. PubMed ID: 24796368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.